⌘K

Login Start Free

Home/Filings/4/0000899243-22-037426

4//SEC Filing

Kirpekar Sahil 4

Accession 0000899243-22-037426

CIK 0001840904other

View on SEC.gov Company Profile

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 4:20 PM ET

Size

5.4 KB

Accession

0000899243-22-037426

Insider Transaction Report

Form 4

Period: 2022-12-01

ATAI Life Sciences N.V.ATAI

Chief Business Officer

Transactions

Award
Stock Option
2022-12-01+750,000→ 750,000 total
Exercise: $3.34Exp: 2032-12-01→ Common Shares (750,000 underlying)

Footnotes (1)

[F1]The stock option shall vest as to 25% of the underlying shares on November 29, 2023, and in 36 substantially equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ATAI Life Sciences N.V.

CIK 0001840904

Entity typeother

Related Parties

1

filerCIK 0001951712

Filing Metadata

Form type: 4
Filed: Dec 1, 7:00 PM ET
Accepted: Dec 2, 4:20 PM ET
Size: 5.4 KB

View on SEC.gov